Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit

Journal of Pain and Symptom Management

Volumn 12, Issue 1, 1996, Pages 18-22

  Monti, Massimo ^a,c   Castellani, Lucia ^a   Berlusconi, Aurelia ^b   Cunietti, Ettore ^a  

^a Palliative Care Unit   (Italy)

^b Laboratory Analysis   (Italy)

^c Ist Geriatrico Pio Albergo T   (Italy)

Author keywords

Anemia; blood transfusion; cancer patient; palliative care

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; SERUM ALBUMIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; DYSPNEA; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; HUMAN; MALE; TERMINAL DISEASE; WELLBEING;

EID: 0029994038     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(96)00044-9     Document Type: Article

References (19)

1. Saunders C. Hospices. In: Duncan AS, Dunstan GR, eds. Dictionary of medical ethics, 2nd ed. London: Welbourn RB, 1981:137-138 .
2. Twycross RG. Symptom control: the problem areas. Palliat Med 1993;7(suppl 1):1-8.
3. Doll DC, Weiss RB. Neoplasia and the erythron. J Clin Oncol 1985;3:429-446.
4. Skillings JR, Sridhar FG, Wong C, Paddock L. The frequency of red cell transfusion for anemia in patients receiving chemotherapy: a retrospective cohort study. Am J Clin Oncol 1993;16:22-25.
5. McKenna RJ. Supportive care and rehabilitation of the cancer patient. In: Holleb AI, Fink DJ, Murphy GP, eds. American Cancer Society textbook of clinical oncology. Atlanta: American Cancer Society, 1991:544-554.
6. Mitchell EP. Blood cell transfusion. In: Schein PS, ed. Decision making in oncology. Philadelphia: BC Decker, 1989: 213.
7. Henry DH. Changing patterns of care in the management of anemia. Semin Oncol 1992; 19(suppl 8):3-7.
8. Turner RA. Haematological aspects of palliative medicine. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1993:486-491.
9. Cruciatti F, Monti M, Cunietti E. The first public hospice in Italy: socio-cultural aspects and staff organization. J Palliat Care 1995;11:33-37.
10. Oken MM, Creech RH, Thormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5: 649-655.
11. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-440.
12. Joint Commission on Accreditation of Health Care Organizations, medical staff monitoring and evaluation: blood usage review, 2nd ed. Chicago: Joint Commission, 1990:7-25.
13. Masouredis SP. Preservation and clinical use of erythrocytes and whole blood. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology, 4th ed. New York: McGraw-Hill, 1990:1628-1647.
14. Mintz PD, Nordine RB, Henry JB, Webb WR. Expected hemotherapy in elective surgery. NY State J Med 1976;76:532.
15. Friedman BA. Patterns of blood utilization by physicians: transfusion of nonoperated anemic patients. Transfusion 1978;18:193.
16. Wachtel TJ, Mor V. The use of transfusion in terminal cancer patients: hospice versus conventional care setting. Transfusion 1985;25:113-115.
17. Sciortino AD, Carlton DC, Axelrod A, Eng M, Zhukovsky DS, Vinciguerra V. The efficacy of administering blood transfusions at home to terminally ill cancer patients. J Palliat Care 1993;9:14-17.
18. Johnson I, Rogers C, Biswas B, Ahmedzai S. What do hospices do? A survey of hospices in the United Kingdom and Republic of Ireland. BMJ 1990;300:791-793.
19. Mozes B, Epstein M, Ben-Bassat I, Modan B, Halkin H. Evaluation of the appropriateness of blood product transfusion using preset criteria. Transfusion 1989;29:473-476.